Jason Jalil

Brain health consequences of digital technology use


G. Small, P. Siddarth, S. Bookheimer, 2020, Dialogues in clinical neuroscience.

CTLA4 blockade increases Th17 cells in patients with metastatic melanoma

A. Ribas, R. Koya, N. Attar, 2009, Journal of Translational Medicine.

Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma

B. Comin-Anduix, A. Ribas, L. Camacho, 2008, Journal of Translational Medicine.

Health-Promoting Strategies for the Aging Brain.

G. Small, Dax Volle, Pauline Wu, 2019, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Natural Killer T Cells in Advanced Melanoma Patients Treated with Tremelimumab

B. Comin-Anduix, A. Ribas, O. Yang, 2013, PloS one.

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

A. Ribas, A. Cochran, Stephen Mok, 2011, Clinical Cancer Research.

Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade

B. Comin-Anduix, A. Ribas, A. Cochran, 2009, Clinical Cancer Research.

Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

F. Marincola, B. Comin-Anduix, A. Ribas, 2009, Clinical Cancer Research.

The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes across a Wide Range of Concentrations

B. Comin-Anduix, A. Ribas, Helena Escuin-Ordinas, 2010, Clinical Cancer Research.